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This commentary proposes a definition for the term “peri-implant phenotype” and
provides a comprehensive description of all its components.
1 INTRODUCTION
Phenotype can be defined as the observable properties of an
organism that are produced by the interaction of the genotype
and the environment.1 The term “phenotype” should not be
used interchangeably with “biotype,” which refers to a set of
organisms that share a specific genotype.
The 2017 World Workshop on the Classification of Peri-
odontal and Peri-Implant Diseases and Conditions defined
the “periodontal phenotype” as the combination of the gin-
gival phenotype, constituted by the keratinized tissue width
and the gingival thickness, and the bone morphotype, that is,
thickness of the alveolar bone plate (Figure 1).2 Meanwhile,
a standard definition for the analogous term “peri-implant
phenotype” is absent from the currently available litera-
ture. Given its relevance in contemporary clinical practice
and research, it is imperative to define this term and its
components.
2 DEFINITION OF THE
PERI-IMPLANT PHENOTYPE
The peri-implant phenotype can be defined as the morpho-
logic and dimensional features characterizing the clinical pre-
sentation of the tissues that surround and support osseointe-
grated implants. The peri-implant phenotype encompasses a
soft tissue component, constituted by the peri-implant kera-
tinized mucosa width, the mucosa thickness and the supracre-
stal tissue height, and an osseous component, characterized
by the peri-implant bone thickness (Figure 2). This defini-
tion does not only apply to buccal and facial sites, but also
to lingual and palatal peri-implant locations. Like the peri-
odontal phenotype, the peri-implant phenotype is site-specific
and may change over time in response to environmental
factors.
3 COMPONENTS OF THE
PERI-IMPLANT PHENOTYPE
3.1 Soft tissue
3.1.1 Keratinized mucosa width
The peri-implant keratinized mucosa width (KMW) is the
height of keratinized soft tissue that runs in an apico-coronal
direction from the mucosal margin to the mucogingival
junction. KMW may be completely absent in specific clinical
situations in which there is only non-keratinized oral mucosa
surrounding dental implants and their corresponding pros-
thetic components. If present, it constitutes the most coronal
component of the peri-implant soft tissues.
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F I G U R E 2 The components of the peri-implant phenotype
Clinical relevance
The need for a minimum amount of KMW for peri-implant
health maintenance, as well as for functional and esthetic
reasons, has been widely investigated and discussed in the lit-
erature and scientific forums. According to the consensus of
Group 4 at the 2017 World Workshop on the Classification
of Periodontal and Peri-Implant Diseases and Conditions, the
evidence is equivocal regarding the effect that the presence or
absence of keratinized mucosa has on the long-term health
of the peri-implant tissues.3 According to Schwarz et al.,
although some studies suggest that the absence of or an inade-
quate amount of KMW may negatively affect self-performed
oral hygiene measures,4–6 there is limited evidence that this
factor constitutes a risk for peri-implantitis.7 However, it is
worth noting the increasing amount of high-level evidence
that associates inadequate KMW (<2 mm) with peri-implant
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mucositis,8,9 as well as the findings of a recent study in which
a minimum amount of 2 mm of KMW was found to be crit-
ical to minimize the incidence of peri-implant mucositis and
future marginal bone loss in erratic maintenance compliers.10
Therefore, although further research is needed to determine
the minimum amount of KMW required for optimal long-term
peri-implant health, function, and esthetics in specific clinical
scenarios, on the basis of current evidence, we propose the fol-
lowing KMW categorization for use in future investigations
and in daily clinical practice: inadequate KMW (<2 mm) and
adequate KMW (≥2 mm).
3.1.2 Mucosal thickness
Peri-implant mucosal thickness (MT) is the horizontal dimen-
sion of the peri-implant soft tissue, which may or may not be
keratinized. Peri-implant MT may vary at different locations
(e.g., buccal versus lingual) and apico-coronal heights respec-
tive to the mucosal margin around a given implant.
Clinical relevance
Similar to the KMW, the thickness of the peri-implant soft
tissue, particularly at the most coronal segment, may play
a critical role on the functional and esthetic outcomes of
implant therapy, as well as on the maintenance of peri-implant
health. The most frequent indication of surgical interventions
aimed at augmenting the MT around implants is to enhance
the esthetic results following the delivery of the final implant-
supported prosthesis. This is commonly performed in an
attempt to attenuate or eliminate the effect of the shade of the
abutment (e.g., titanium alloy, gold, or zirconia) on the buccal
aspect of the mucosa11–16 and/or to compensate for possible
underlying bone deficiencies resulting from unfavorable
osseous remodeling patterns, prior to or after functional
loading.17–19 Although the vast majority of studies conducted
in this area have focused on the effect of MT augmentation
for esthetic purposes, a recent systematic review reported
that the performance of soft tissue grafting procedures
for gain of MT resulted in significantly less interproximal
marginal bone loss over time.20 A consensus on the minimum
MT required to achieve predictable long-term functional and
esthetic outcomes, and to minimize marginal bone loss and
mucosal recession, has not been established.21 However,
most studies in this topic found that the effect of the abutment
shade on the mucosa was negated in sites that exhibited
a minimum MT of ≈2 mm.13–15 Hence, we propose the
following MT categorization for use in future investigations
and in daily clinical practice: thin MT (<2 mm) and thick
MT (≥2 mm).
3.1.3 Supracrestal tissue height
The peri-implant supracrestal tissue height (STH) is the verti-
cal dimension of the soft tissue that surrounds a dental implant
from the mucosal margin to the crestal bone. Different from
KMW and MT, this component of the peri-implant soft tis-
sue phenotype can be assessed circumferentially around an
implant, including proximal sites. STH should not be used
interchangeably with the analogous term “supracrestal tis-
sue attachment,” which only applies to natural teeth, and
that has recently replaced the classic term “biologic width.”2
Biologic width is a histologic concept that was originally
described around natural teeth and can be defined as the ver-
tical distance from the base of the sulcular epithelium to
the crestal bone, including the junctional epithelium and the
attached connective tissue.22 In a corono-apical direction, the
peri-implant STH encompasses the sulcular epithelium, the
junctional epithelium, and the supracrestal connective tissue,
which is typically not attached to the abutment surface. As
noted by Araujo and Lindhe, several investigations23–26 have
demonstrated that the STH is usually taller than the supracre-
stal tissue attachment around teeth to an average magnitude of
an additional 1.0 to 1.5 mm in both buccal/lingual and proxi-
mal sites.27
Clinical relevance
Understanding the effect of STH on peri-implant bone remod-
eling is one of the keys to achieving predictable outcomes in
the context of tooth replacement therapy via dental implants.
Noteworthy, the available evidence is quite robust in this area.
According to the findings reported in multiple clinical stud-
ies published over the past decade,28–34 the STH plays a criti-
cal role in marginal bone loss patterns. Short STH at the time
of implant placement has been consistently associated with
a variable amount of marginal bone loss, likely because of
the physiologic establishment of the soft tissue component of
the implant-supporting apparatus during the healing period.
Current evidence indicates that this concept applies indepen-
dently of the implant design (e.g., bone versus soft tissue level
implant) and the restorative modality (e.g., platform switch-
ing). A systematic review aimed at evaluating the effect of
STH on marginal bone loss indicated that not all the stud-
ies on this topic report a cut-off value to distinguish between
short (unfavorable) or tall (favorable) STH, but, those that did,
established the threshold at 2 or 3 mm.35 Considering the most
recent evidence in this topic,36,37 as well as the anatomical
differences between anterior and posterior teeth (i.e., anterior
teeth tend to exhibit a longer STH), we propose the follow-
ing STH categorization for use in future investigations and
in daily clinical practice: short STH (<3 mm) and tall STH
(≥3 mm).
A word of caution must be added. According to the results
of a recently published study, implants surrounded by a deep
mucosal tunnel (≥3 mm) above the implant restorative plat-
form were associated with a less favorable pattern of resolu-
tion of peri-implant mucositis as compared to sites presenting
a mucosal tunnel of ≤1 mm.38 As it is commonly stated in
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the field of Oral Implantology, dental implants should be
placed “as deep as necessary, but as shallow as possible,”
accounting for site-specific anatomic and restorative factors.
3.2 Bone
3.2.1 Peri-implant bone thickness
The peri-implant bone thickness (PBT) is the horizontal
dimension of osseous tissue that supports an osseointegrated
implant. PBT may vary at different apico-coronal heights
respective to the bone crest around a given implant or even
be completely absent in sites exhibiting peri-implant bone
defects (e.g. fenestrations or dehiscences).
Clinical relevance
Although it is generally acknowledged that thick peri-implant
bone, particularly at the coronal level, is associated with favor-
able implant therapy outcomes,39 and a recent, highly relevant
preclinical study has shed light in this topic,40 there is limited
clinical evidence to establish a minimum threshold of bone
thickness necessary to achieve predictable peri-implant tis-
sue stability, esthetics, and health. In fact, as pointed out by
Thoma et al. in a systematic review aimed at evaluating the
efficacy of bone augmentation procedures to treat horizon-
tal ridge deficiencies after implant placement, vertical bone
defect (dehiscence) resolution appears to be more important
than the horizontal bone thickness at the implant shoulder.41
Even so, this does not necessarily mean that PBT is irrelevant.
The most important piece of available clinical evidence per-
taining to the role of PBT in the maintenance of peri-implant
health emanates from the findings of a large prospective study
including >3000 implants placed in 32 different health care
centers.42 The authors of this study reported that sites pre-
senting a PBT of at least 2 mm at ≈0.5 mm apical to the crest
at the time of implant placement exhibited a lower rate of ver-
tical bone loss and slightly lower implant failure rate between
6 and 8 months after implant insertion. In spite of its relatively
limited scope, short-term follow-up and other methodological
limitations pointed out by Merheb et al.,43 the findings of this
study should be taken into consideration until further clinical
evidence is generated. Hence, we propose the following PBT
categorization for use in future investigations and in daily clin-
ical practice: thin PBT (<2 mm) and thick PBT (≥2 mm).
4 SUMMARY AND FINAL
REMARKS
The four components of the peri-implant phenotype are the
KMW, the MT, the STH, and the PBT. The dimensional
thresholds hereby proposed for each of them derive from
a meticulous assessment of the available literature filtered
through the clinical experience of the authors. Nevertheless,
it is important to remark that these average threshold values
may vary depending on tooth location (anterior versus
posterior) and may not be applicable in specific situations
in which the characteristics of the implant-supporting
apparatus deviate from normal, including sites undergoing
local inflammatory processes that may directly influence
the dimensions, morphology and/or integrity of the peri-
implant tissues. Future research is necessary to determine
the minimum amount of KMW, MT, STH, and PBT required
to obtain optimal short- and long-term outcomes, including
maintenance of peri-implant health, function, and esthetics,
in specific clinical scenarios (e.g., patients with uncontrolled
systemic conditions, the use of different biomaterials and
variations in abutment design, among other factors). It is also
important to elucidate the role of PBT on peri-implant health
and soft tissue stability, and whether there is a dimensional
correlation between peri-implant soft and hard tissues.
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